Author:
Jakubowska Beata,Pietrzyk Ewelina,Maciejewicz Piotr,Kowalewski Cezary,Wozniak Katarzyna
Abstract
IntroductionMucous membrane pemphigoid (MMP) is diagnosed on the basis of a characteristic clinical picture (a predilection for mucosal involvement and scarring in the affected tissues) and a positive direct immunofluorescence (DIF) result.MethodsIn this study, we compare the diagnostic and prognostic values of conjunctival and oral biopsies analyzed by DIF in patients with MMP. Sixteen patients with MMP and mucosal involvement as a predominant symptom were classified into three groups based on the clinical picture. Oral and conjunctival DIF were performed on all patients.ResultsOur study showed that patients with simultaneous oral and conjunctival involvement had a positive oral DIF in 83% and a positive ocular DIF in 100% of the examined cases, respectively. Patients with isolated ocular MMP had a positive oral DIF in 50% and a positive ocular DIF in 66% of the examined cases, respectively. Patients with only oral involvement with MMP had a positive oral DIF in 100% and a positive ocular DIF in 50% of the examined cases, respectively.DiscussionOral biopsy should be performed first and is usually sufficient for the diagnosis, even in patients with exclusively ocular MMP, whereas in patients without clinical ocular involvement, ocular DIF is positive in half of the cases and may be a predictive factor for ocular lesions in the future.
Reference18 articles.
1. Ocular mucous membrane pemphigoid: a review;Taurone;Immunol Res,2019
2. Ocular mucous membrane pemphigoid: current state of pathophysiology, diagnostics and treatment;Georgoudis;Ophthalmol Ther,2019
3. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators;Chan;Arch Dermatol,2002
4. Ocular cicatricial pemphigoid (review);Branisteanu;Exp Ther Med,2020
5. Reliability of conjunctival biopsy for diagnosis of ocular mucous membrane pemphigoid: redetermination of the standard for diagnosis and outcomes of previously biopsy-negative patients;Anesi;Ocul Immunol Inflamm,2021